In the gastric metastasis model, the use of the pharmaceutical agent Odanacatib significantly inhibited the metastases of cancer cells, suggesting that Cathepsin K inhibition may be employed as a new therapeutic strategy to prevent tumor metastasis [41,42,43]. Here, CTSK is linked to cancer.